Stephen J. Capuzzi

ORCID: 0000-0003-0001-8211
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Computational Drug Discovery Methods
  • Bioinformatics and Genomic Networks
  • Protein Degradation and Inhibitors
  • Machine Learning in Materials Science
  • Biomedical Text Mining and Ontologies
  • Animal testing and alternatives
  • Advanced Biosensing Techniques and Applications
  • Metabolomics and Mass Spectrometry Studies
  • Genetics, Bioinformatics, and Biomedical Research
  • Contact Dermatitis and Allergies
  • Dermatology and Skin Diseases
  • Genomics and Rare Diseases
  • Biosimilars and Bioanalytical Methods
  • Photoreceptor and optogenetics research
  • Click Chemistry and Applications
  • Medical Imaging Techniques and Applications
  • Cell Image Analysis Techniques
  • Gastrointestinal Tumor Research and Treatment
  • Synthesis and Reactivity of Heterocycles
  • Chemistry and Chemical Engineering
  • Cholinesterase and Neurodegenerative Diseases
  • Semantic Web and Ontologies
  • Synthesis and biological activity
  • 3D Printing in Biomedical Research
  • Quinazolinone synthesis and applications

University of North Carolina at Chapel Hill
2015-2024

University of North Carolina Health Care
2023

Communities In Schools of Orange County
2016

Institute of Medicinal Plant Development
2016

Fox Chase Cancer Center
2015

Saint Joseph's University
2012

Michael P. Menden Dennis Wang Mike J. Mason Bence Szalai Krishna C. Bulusu and 95 more Yuanfang Guan Thomas Yu Jaewoo Kang Minji Jeon Russ Wolfinger Tin Nguyen Mikhail Zaslavskiy Jordi Abante Barbara Schmitz Abecassis Nanne Aben Delasa Aghamirzaie Tero Aittokallio Farida S. Akhtari Bissan Al‐Lazikani Tanvir Alam Amin Allam Chad H. G. Allen Mariana Pelicano de Almeida Doaa Altarawy Vinícius M. Alves Alicia Amadoz Benedict Anchang Albert A. Antolín Jeremy R. Ash V. Aznar Wail Ba-Alawi Moeen Bagheri Vladimir B. Bajić G. C. Ball Pedro J. Ballester Delora Baptista Christopher Bare Mathilde Bateson Andreas Bender Denis Bertrand Bhagya K. Wijayawardena Keith A. Boroevich Evert Bosdriesz Salim Bougouffa Gergana Bounova Thomas Brouwer Barbara M. Bryant Manuel Calaza Alberto Calderone Stefano Calza Stephen J. Capuzzi José Carbonell‐Caballero Yichao Li Hannah Carter Luisa Castagnoli Remzi Çelebi Gianni Cesareni Hyeokyoon Chang Guocai Chen Hao Chen Huiyuan Chen Lijun Cheng Ariel Chernomoretz Davide Chicco Kwang‐Hyun Cho Sung‐Hwan Cho Daeseon Choi Jaejoon Choi Kwanghun Choi Min‐Soo Choi Martine De Cock Elizabeth A. Coker Isidro Cortés‐Ciriano Miklós Cserzö Cankut Çubuk Charles Curtis Dries Van Daele Cuong Cao Dang Tjeerd M. H. Dijkstra Joaquı́n Dopazo Sorin Drăghici Anastasios Drosou Michel Dumontier Friederike Ehrhart Fatma-Elzahraa Eid Mahmoud ElHefnawi Haitham Elmarakeby Bo van Engelen H. Billur Engin Iwan J. P. de Esch Chris T. Evelo André O. Falcão Sherif Farag Carlos Fernández-Lozano Kathleen M. Fisch Åsmund Flobak Chiara Fornari Amir Foroushani Donatien Chedom Fotso Denis Fourches

Abstract The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop resistance that might be overcome with drug combinations. However, the number possible combinations vast, necessitating data-driven approaches to find optimal patient-specific treatments. Here we report AstraZeneca’s large combination dataset, consisting 11,576 experiments from 910 across 85 molecularly characterized cell lines, and results a DREAM Challenge evaluate computational strategies for...

10.1038/s41467-019-09799-2 article EN cc-by Nature Communications 2019-06-17

The use of substructural alerts to identify Pan-Assay INterference compoundS (PAINS) has become a common component the triage process in biological screening campaigns. These alerts, however, were originally derived from proprietary library tested just six assays measuring protein–protein interaction (PPI) inhibition using AlphaScreen detection technology only; moreover, 68% (328 out 480 alerts) four or fewer compounds. In an effort assess reliability these as indicators pan-assay...

10.1021/acs.jcim.6b00465 article EN publisher-specific-oa Journal of Chemical Information and Modeling 2017-02-06

Protein kinases are highly tractable targets for drug discovery. However, the biological function and therapeutic potential of majority 500+ human protein remains unknown. We have developed physical virtual collections small molecule inhibitors, which we call chemogenomic sets, that designed to inhibit catalytic almost half kinases. In this manuscript share our progress towards generation a comprehensive kinase set (KCGS), release kinome profiling data large inhibitor (Published Kinase...

10.1371/journal.pone.0181585 article EN cc-by PLoS ONE 2017-08-02

Structural alerts are widely accepted in chemical toxicology and regulatory decision support as a simple transparent means to flag potential hazards or group compounds into categories for read-across. However, there has been growing concern that disproportionally too many chemicals toxic, which questions their reliability toxicity markers. Conversely, the rigorously developed properly validated statistical QSAR models can accurately reliably predict of chemical; however, use hampered by lack...

10.1039/c6gc01492e article EN Green Chemistry 2016-01-01
Kamel Mansouri Agnes L. Karmaus Jeremy Fitzpatrick Grace Patlewicz Prachi Pradeep and 95 more Domenico Alberga Nathalie Alépée Timothy E. H. Allen Dave Allen Vinícius M. Alves Carolina Horta Andrade Tyler R. Auernhammer Davide Ballabio Shannon Bell Emilio Benfenati Sudin Bhattacharya Joyce V. Bastos Stephen A. Boyd J.B. Brown Stephen J. Capuzzi Yaroslav Chushak Heather L. Ciallella Alex M. Clark Viviana Consonni Pankaj Daga Sean Ekins Sherif Farag Maxim V. Fedorov Denis Fourches Domenico Gadaleta Feng Gao Jeffery M. Gearhart Garett Goh Jonathan M. Goodman Francesca Grisoni Chris Grulke Thomas Härtung Matthew Hirn Pavel Karpov Alexandru Korotcov Giovanna J. Lavado Michael S. Lawless Xinhao Li Thomas Luechtefeld Filippo Lunghini Giuseppe Felice Mangiatordi Gilles Marcou Dan H. Marsh Todd M. Martin Andrea Mauri Eugene Muratov Glenn J. Myatt Ðắc-Trung Nguyễn Orazio Nicolotti Reine Note Paritosh Pande Amanda K. Parks Tyler Peryea Ahsan Habib Polash Robert Ralló Alessandra Roncaglioni Craig Rowlands Patricia Ruiz Daniel P. Russo Ahmed E Sayed Risa Sayre Timothy Sheils Charles Siegel Arthur C. Silva Anton Simeonov Sergey Sosnin Noel Southall Judy Strickland Yun Tang Brian J. Teppen Igor V. Tetko Dennis Thomas Valery Tkachenko Roberto Todeschini Cosimo Toma Ignacio J. Tripodi Daniela Trisciuzzi Alexander Tropsha Alexandre Varnek Kristijan Vuković Zhongyu Wang Liguo Wang Katrina M. Waters Andrew J. Wedlake Sanjeeva J. Wijeyesakere Dan Wilson Zijun Xiao Hongbin Yang Gergely Zahoránszky-Kőhalmi Alexey Zakharov Fagen F. Zhang Zhen Zhang Tongan Zhao Hao Zhu Kimberley M. Zorn

la diffusion de documents scientifiques niveau recherche, publiés ou non, émanant des établissements d'enseignement et recherche français étrangers, laboratoires publics privés.

10.1289/ehp8495 article FR public-domain Environmental Health Perspectives 2021-04-01

Abstract Despite decades of intensive search for compounds that modulate the activity particular protein targets, a large proportion human kinome remains as yet undrugged. Effective approaches are therefore required to map massive space unexplored compound–kinase interactions novel and potent activities. Here, we carry out crowdsourced benchmarking predictive algorithms kinase inhibitor potencies across multiple families tested on unpublished bioactivity data. We find top-performing...

10.1038/s41467-021-23165-1 article EN cc-by Nature Communications 2021-06-03

Deep generative neural networks have been used increasingly in computational chemistry for de novo design of molecules with desired properties. Many deep learning approaches employ reinforcement optimizing the target properties generated molecules. However, success this approach is often hampered by problem sparse rewards as majority are expectedly predicted inactives. We propose several technical innovations to address and improve balance between exploration exploitation modes learning. In...

10.1038/s42004-022-00733-0 article EN cc-by Communications Chemistry 2022-10-18

The ability to determine which environmental chemicals pose the greatest potential threats human health remains one of major concerns in regulatory toxicology. Computation methods that can accurately predict chemicals' toxic silico are increasingly sought-after replace vitro high-throughput screening (HTS) as well controversial and costly vivo animal studies. To this end, we have built Quantitative Structure-Activity Relationship (QSAR) models twelve (12) stress response nuclear receptor...

10.3389/fenvs.2016.00003 article EN cc-by Frontiers in Environmental Science 2016-02-04

We describe SGC-GAK-1 (11), a potent, selective, and cell-active inhibitor of cyclin G-associated kinase (GAK), together with structurally related negative control SGC-GAK-1N (14). 11 was highly selective in an vitro kinome-wide screen, but cellular engagement assays defined RIPK2 as collateral target. identified 18 potent lacking GAK activity. Together, this chemical probe set can be used to interrogate biology.

10.1021/acs.jmedchem.8b01213 article EN Journal of Medicinal Chemistry 2019-02-15

An example of structural transformation human skin sensitizers into various non-sensitizers based on interpretation QSAR models.

10.1039/c6gc01836j article EN Green Chemistry 2016-01-01

The enormous increase in the amount of publicly available chemical genomics data and growing emphasis on sharing open science mandates that cheminformaticians also make their models for broad use by scientific community. Chembench is one first accessible, integrated cheminformatics Web portals. It has been extensively used researchers from different fields curation, visualization, analysis, modeling chemogenomics data. Since its launch 2008, accessed more than 1 million times 5000 users a...

10.1021/acs.jcim.6b00462 article EN Journal of Chemical Information and Modeling 2017-01-03

Elucidation of the mechanistic relationships between drugs, their targets, and diseases is at core modern drug discovery research. Thousands studies relevant to drug–target–disease (DTD) triangle have been published annotated in Medline/PubMed database. Mining this database affords rapid identification all that confirm connections vertices or enable new inferences such connections. To end, we describe development Chemotext, a publicly available Web server mines entire compendium literature...

10.1021/acs.jcim.7b00589 article EN Journal of Chemical Information and Modeling 2018-01-04

Multiple approaches to quantitative structure–activity relationship (QSAR) modeling using various statistical or machine learning techniques and different types of chemical descriptors have been developed over the years. Oftentimes models are used in consensus make more accurate predictions at expense model interpretation. We propose a simple, fast, reliable method termed Multi-Descriptor Read Across (MuDRA) for developing both interpretable models. The is conceptually related well-known kNN...

10.1021/acs.jcim.8b00124 article EN Journal of Chemical Information and Modeling 2018-05-29

Traditionally, the skin sensitization potential of chemicals has been assessed using animal models. Due to growing ethical, political, and financial concerns, sustainable alternatives testing need be developed. As publicly available data continues grow, computational approaches, such as alert-based systems, read-across, QSAR models, are expected reduce or replace for prediction human potential. Herein, we discuss current approaches predicting provide future perspectives field. a...

10.1021/acssuschemeng.7b04220 article EN ACS Sustainable Chemistry & Engineering 2018-02-07

Abstract Chordoma is a devastating rare cancer that affects one in million people. With mean-survival of just 6 years and no approved medicines, the primary treatments are surgery radiation. In order to speed new medicines chordoma patients, drug repurposing strategy represents an attractive approach. Drugs have already advanced through human clinical safety trials potential be more quickly than de novo discovered on targets. We taken two strategies enable this: (1) generated validated...

10.1038/s41598-020-70026-w article EN cc-by Scientific Reports 2020-07-31

The Ebola virus (EBOV) causes severe human infection that lacks effective treatment. A recent screen identified a series of compounds block EBOV-like particle entry into cells. Using data from this screen, quantitative structure–activity relationship models were built and employed for virtual screening ∼17 million compound library. Experimental testing 102 hits yielded 14 with IC50 values under 10 μM, including several sub-micromolar inhibitors, more than 10-fold selectivity against host...

10.1021/acs.jmedchem.8b00035 article EN Journal of Medicinal Chemistry 2018-04-06

Approximately 10–15 % of gastrointestinal stromal tumors (GISTs) lack gain function mutations in the KIT and platelet-derived growth factor receptor alpha (PDGFRA) genes. An alternate mechanism oncogenesis through loss succinate-dehydrogenase (SDH) enzyme complex has been identified for a subset these "wild type" GISTs. Paired tumor normal DNA from an SDH-intact wild-type GIST case was subjected to whole exome sequencing identify pathogenic mechanism(s) this tumor. Selected findings were...

10.1186/s12885-015-1872-y article EN cc-by BMC Cancer 2015-11-10

Small, colloidally aggregating molecules (SCAMs) are the most common source of false positives in high-throughput screening (HTS) campaigns. Although SCAMs can be experimentally detected and suppressed by addition detergent assay buffer, sensitivity is not routinely monitored HTS. Computational methods thus needed to flag potential during HTS triage. In this study, we have developed rigorously validated quantitative structure-interference relationship (QSIR) models detergent-sensitive...

10.1021/acs.jcim.0c00415 article EN Journal of Chemical Information and Modeling 2020-07-17

Abstract Protein kinases are highly tractable targets for drug discovery. However, the biological function and therapeutic potential of majority 500+ human protein remains unknown. We have developed physical virtual collections small molecule inhibitors, which we call chemogenomic sets, that designed to inhibit catalytic almost half kinases. In this manuscript share our progress towards generation a comprehensive kinase set (KCGS), release kinome profiling data large inhibitor (Published...

10.1101/104711 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2017-01-31
Coming Soon ...